1. Biochemistry and Chemical Biology
  2. Cell Biology

Translation inhibitory elements from Hoxa3 and Hoxa11 mRNAs use uORFs for translation inhibition

  1. Fatima Alghoul
  2. Schaeffer Laure
  3. Gilbert Eriani
  4. Franck Martin  Is a corresponding author
  1. Institut de Biologie Moléculaire et Cellulaire, “Architecture et Réactivité de l’ARN” CNRS UPR9002, Université de Strasbourg, France
https://doi.org/10.7554/eLife.66369
Share this article
Cite this article
  1. Fatima Alghoul
  2. Schaeffer Laure
  3. Gilbert Eriani
  4. Franck Martin
(2021)
Translation inhibitory elements from Hoxa3 and Hoxa11 mRNAs use uORFs for translation inhibition
eLife 10:e66369.
https://doi.org/10.7554/eLife.66369
  2. Download BibTeX
  3. Download .RIS

Abstract

During embryogenesis, Hox mRNA translation is tightly regulated by a sophisticated molecular mechanism that combines two RNA regulons located in their 5’UTR. First, an internal ribosome entry site (IRES) enables cap-independent translation. The second regulon is a translation inhibitory element or TIE, which ensures concomitant cap-dependent translation inhibition. In this study, we deciphered the molecular mechanisms of mouse Hoxa3 and Hoxa11 TIEs. Both TIEs possess an upstream open reading frame (uORF) that is critical to inhibit cap-dependent translation. However, the molecular mechanisms used are different. In Hoxa3 TIE, we identify an uORF which inhibits cap-dependent translation and we show the requirement of the non-canonical initiation factor eIF2D for this process. The mode of action of Hoxa11 TIE is different, it also contains an uORF but it is a minimal uORF formed by an uAUG followed immediately by a stop codon, namely a ‘start-stop’. The ‘start-stop’ sequence is species-specific and in mice, is located upstream of a highly stable stem loop structure which stalls the 80S ribosome and thereby inhibits cap-dependent translation of Hoxa11 main ORF.

Introduction

Gene expression constitutes an indispensable cellular process for which the genetic information encodes a functional product, mainly proteins. This process named translation initiates by a cap-dependent mechanism for most cellular mRNAs. It involves a large number of auxiliary proteins termed eukaryotic initiation factors (eIFs) which are required for the recruitment of the ribosomes on the mRNA (Hinnebusch, 2014; Merrick and Pavitt, 2018; Pelletier and Sonenberg, 2019; Shirokikh and Preiss, 2018). To ensure fine-tuning of translation, this step is highly regulated. However, several mRNA subclasses are translated by non-canonical mechanisms. For instance, this is the case for homeobox (Hox) mRNAs. Hox genes encode a family of proteins that constitutes transcription factors. Their main function is to orchestrate specific sequential transcription processes during embryonic development. A wealth of experimental data over the last three decades has led to the identification of many cis-regulatory elements that control Hox gene transcriptional patterns, thus giving deeper insights into the expression of Hox mRNAs (Alexander et al., 2009). In fact, Hox homologues in Drosophila, precisely Antp and Ubx genes in the Hom-C cluster, have been suggested to be under translational control during embryonic development (Oh et al., 1992). A subgroup of mRNAs produced from the Antp and Ubx loci contain functional internal ribosome entry sites (IRES) that allow their translation using a cap-independent mechanism during development (Ye et al., 1997). More recently, the presence of other IRES elements in the 5’UTR of subsets of mice HoxA mRNAs (Hoxa3, Hoxa4, Hoxa5, Hoxa9, and Hoxa11) has been demonstrated (Leppek et al., 2020; Xue et al., 2015). Some of these IRES require the presence of the ribosomal protein RpL38 in the ribosome to efficiently initiate translation, thereby explaining the tissue patterning defective phenotype observed with RpL38 knockout mouse (Kondrashov et al., 2011). The IRES activity in these Hox mRNAs was found to be critical for their appropriate expression. Upon the discovery of the IRES elements in Hox mRNAs, other RNA regulons termed translation inhibitory elements (TIEs) were also found in the 5’UTR of Hox mRNAs (Xue et al., 2015). TIEs are located upstream of the previously described IRES. According to the study by Xue et al., 2015, these elements efficiently inhibit canonical cap-dependent translation in subsets of HoxA mRNAs (Hoxa3, Hoxa4, Hoxa9, and Hoxa11) by an unknown mechanism (Xue et al., 2015). The action of TIE that ensures efficient blockage of cap-dependent translation promotes IRES-mediated cap-independent translation. TIE and IRES act in synergy to ensure tightly regulated translation during organismal development. Indeed, it has been shown that Hox TIEs ensure that Hox mRNAs are translated solely by their IRES element. Thereby, TIEs represent the first example of specific RNA elements dedicated to inhibiting specifically cap-dependent translation in Hox mRNAs. However, the mechanism of action of these elements as well as their structural characterization are still unknown. In this study, we investigate the functional mode of action of TIEs from Hoxa3 and Hoxa11 mRNAs that were previously identified and characterized by Xue et al., 2015. Our study was conducted on Hoxa3 and Hoxa11 for several reasons. First, among Hox mRNAs, the translation mechanism used for each is distinct (Xue et al., 2015), Hoxa11 mRNA translation being RpL38-dependent while Hoxa3 is RpL38-independent. Second, these two TIEs have very efficient translation inhibition rate and third, their relatively short lengths were more suitable for our experiments. First, we determined their secondary structure by chemical probing assays and then, using cell-free translation extracts and in vivo assays, we deciphered their mode of action. Interestingly, the translation inhibitory mechanism that is mediated by Hoxa3 TIE is radically distinct from the one used by Hoxa11. Hoxa3 TIE contains an uORF that is translated into a 9 KDa protein through the Hoxa3 IRES and that requires the presence of the non-canonical translation initiation factor eIF2D. Indeed, eIF2D has been shown to be involved in diverse functions from translation initiation on specific mRNAs to reinitiation and recycling (Dmitriev et al., 2010; Skabkin et al., 2010; Weisser et al., 2017). On the contrary, Hoxa11 TIE contains a long stable hairpin structure which is preceded by a start-stop codon combination. In mice, these three elements enable a highly efficient inhibition of cap-dependent translation by Hoxa11 TIE that is achieved through a start-stop stalling mechanism of an 80S ribosome.

Results

TIE-mediated inhibition recapitulated in rabbit reticulocyte lysate

To dissect the mechanism of TIE-mediated inhibition, we first set up an efficient cell-free assay. We used rabbit reticulocyte lysate (RRL) and performed in vitro experiments using several reporter constructs. To analyse their translation efficiency, capped mRNAs were translated in RRL in the presence of [35S]-methionine to verify the size of the expected synthesized protein and luciferase activity was measured to determine their translation efficiency. In order to standardize the measured translation activities, we inserted the TIEs identified and characterized by Xue et al., 2015, in murine Hoxa3 and mRNAs upstream of the well-characterized human β-globin (Hbb-b1) 5’UTR (Figure 1A). The Hbb-b1 allows translation strictly by a cap-dependent mechanism (Fletcher et al., 1990). Therefore, in order to evaluate the inhibition due to TIEs, we used a reporter mRNA containing the sole Hbb-b1 5’UTR placed upstream of Renilla luciferase (RLuc) coding sequence as a control reporter gene. First, we demonstrated that translation with these extracts is cap-dependent (Figure 1—figure supplement 1A). Second, we performed translation experiments with increasing amounts of the same mRNA and determined that with concentrations higher than 100 nM, the translation yield reached a plateau (Figure 1—figure supplement 1A). In order to avoid any titration effect due to excess of mRNA, we performed all translation assays at an mRNA concentration of 50 nM, which enables sub-saturating conditions. Hoxa3 and Hoxa11 TIEs efficiently promote a translation inhibition by 79% and 91%, respectively (Figure 1A). Therefore, our cell-free translation assay using RRL efficiently recapitulates the previously described TIE-mediated translation inhibition (Xue et al., 2015). Likewise, TIE-mediated inhibition was efficiently recapitulated in other cell-free translation systems, which are partially or fully cap-dependent from other organisms like wheat germ extracts, Drosophila S2 cell extracts, and human HeLa cell extracts (Figure 1—figure supplement 1B). Moreover, the same constructs were introduced in a plasmid that allowed us to monitor translation inhibition in vivo. We tested two cell lines that have been shown to express Hox genes, namely human HEK293T and murine mesenchymal stem cell line C3H10T1/2 (Phinney et al., 2005). In these cells, translation inhibition by Hoxa3 and Hoxa11 TIE is 98% and 88%, respectively (Figure 1—figure supplement 1C). Next, to define the minimal active domains of Hoxa3 and Hoxa11, sequential 5’ deletions were performed. In each experiment, translation for each construct was compared to the control (w/o TIE) (Figure 1B). First, we tested large deletions in order to roughly determine the functional domain (Figure 1—figure supplement 1D), then more precise deletions to map exactly the 5’ end of functional domains for Hoxa3 and Hoxa11 (Figure 1B). Deletion of 68 nts in Hoxa3 TIE does not affect inhibition (81%). A further deletion of 113 nts completely abolishes the translation inhibition of Hoxa3 TIE (10%). Therefore, the minimal Hoxa3 element encompasses nucleotides 68–170. Concerning Hoxa11 TIE, the situation is not as clear. In fact, the inhibition is completely lost when 161 nts are deleted. In this case, the deletions indicate that elements essential for translation inhibition are most likely located between residues 139 and 161. In conclusion, these experiments allowed the localization of essential RNA elements required for Hoxa3 and Hoxa11 RNA regulons that are required to retain their full inhibitory function.

Figure 1 with 1 supplement see all
Download asset Open asset
Translation inhibitory element (TIE)-mediated inhibition is recapitulated in rabbit reticulocyte lysate (RRL) and does not require full-length TIEs.

(A) Three capped mRNAs were used to test TIE-mediated inhibition in vitro. Hoxa3 TIE and Hoxa11 TIE were placed upstream of the 5’UTR of Hbb-b1 and the Renilla luciferase coding sequence. Translation assays were performed in vitro using RRL at an mRNA concentration of 50 nM, which enables sub-saturating conditions. The relative expression of luciferase protein reflects the efficiency of translation inhibition by Hoxa3 TIE and Hoxa11 TIE. Values were normalized to that of the control (w/o TIE) which corresponds to normal expression without inhibition and was set to 100%. **p<0.01 (t-test as compared to w/o TIE). n = 3. Experiments were performed in triplicates. (B) Sequential deletions in the 5’ extremity of Hoxa3 TIE and Hoxa11 TIE constructs were performed to assay their effect on translation. Values of translation expression were normalized to that of the control (w/o TIE). Experiments were performed in triplicates. The percentages of inhibition for each TIE are indicated in the histogram. **p<0.01 (t-test as compared to w/o TIE). n = 3. Experiments were performed in triplicates.

TIEs have distinct secondary structures

To gain further insights into the structural and functional properties of TIEs, we performed chemical probing using dimethyl sulfate (DMS) and 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate (CMCT) reagents for both Hoxa3 TIE and Hoxa11 TIE (Figure 2). Since modifications were performed in triplicates, the average of reactivity was calculated for each nucleotide at a specific position (Figure 2—figure supplement 1). With this reactivity, we built a secondary structural model for both Hoxa3 and Hoxa11 TIEs. Hoxa3 TIE contains a 5’ proximal stem loop and another bigger structure comprising two-way junctions (Figure 2A). For TIE a11, the higher GC content (64%) than Hoxa3 TIE (45%) suggests more stable structure. Our probing experiments confirmed this statement. It comprises four stem loops and a three-way junction structure (Figure 2B). To further validate our models, the secondary structures of both TIEs were also probed in the frame of the full-length Hox 5’UTR which contains the IRES element downstream of the TIE. The reactivities for each nucleotide obtained with isolated TIEs and with TIEs embedded in full-length 5’UTR were highly similar suggesting that the TIEs do fold independently from the IRES (Figure 2—figure supplement 1). Using these two models, we wanted to further characterize the structure-function relationships of both TIEs.

Figure 2 with 1 supplement see all
Download asset Open asset
The secondary structural models of Hoxa3 translation inhibitory element (TIE) and Hoxa11 TIE reveal distinct structures.

The structures of (A) Hoxa3 TIE (170 nucleotides) and (B) Hoxa11 TIE (216 nucleotides) were obtained by chemical probing using base-specific reagents, dimethyl sulfate (DMS) and 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate (CMCT). After modifications, reverse transcription was performed using fluorescently labelled primers to determine the position of modified nucleotides. Experiments were performed in triplicates. Reactivities are shown as average reactivity from three independent experiments. A representation of reactivities is assigned as colour code depending on a range of values as shown in the figure legend on the right. Reactivity values for each nucleotide with corresponding standard deviations are shown in figure supplements (S2A, S2B, S2C, and S2D).

Hoxa3 TIE contains an uORF that inhibits translation

The 5’ truncations experiments allowed us to pinpoint critical elements required for translation inhibition. Interestingly, the minimal Hoxa3 contains putative uORFs starting from two putative uAUGs at positions 111–113 and 123–125, respectively (Figure 3A). In order to test their implication in the translation inhibition, both uAUGs were mutated independently into UAC thereby eliminating any possibility of AUG-like codon recognition. Interestingly, the mutation of AUG111 completely abolishes the inhibition by Hoxa3 TIE thereby confirming its implication. On the contrary, this is not the case for AUG123 (Figure 3A). This is in good agreement with the fact that AUG111 has an optimal Kozak sequence (A at −3 and G at +4), thereby the ribosome initially recognizes it during scanning along the 5’UTR Kozak, 1986. To further confirm the assembly of the ribosome on uAUG111, we mutated it into AUG-like codons. We tested previously described AUG-like codons such as AUU, CUG, GUG, and ACG. None of the tested AUG-likes are used for translation inhibition indicating that Hoxa3 TIE requires a genuine AUG start codon (Figure 3—figure supplement 1A, left panel). Since the AUG111 is involved in a stem, it is possible that the absence of inhibition with the AUG-likes is actually due to the disruption of the stem. To rule out this possibility, we mutated the AUG111 into CUG and GUG and inserted simultaneously the compensatory mutations in AUG123 into AGG and ACG respectively that enable the formation of the stem with the mutated CUG and GUG codons (Figure 3—figure supplement 1A, right panel). In both mutants, the inhibition was fully destroyed indicating that efficient inhibition requires a genuine AUG start codon independently of the secondary structure (Figure 3—figure supplement 1A). Next, we confirmed the use of uAUG111 by toe printing assay. As expected, a canonical +16 reverse transcription (RT) arrest from uAUG111 was clearly detected with GMP-PNP, a non-hydrolysable analogue of GTP that prevents subunit joining (Eliseev et al., 2018), and less efficiently with cycloheximide, a translocation inhibitor that binds the E-site of the ribosome (Garreau de Loubresse et al., 2014; Schneider-Poetsch et al., 2010). Accordingly, when the uAUG is mutated to UAC, the +16 toe print disappears (Figure 3B). Altogether, this data confirm that a pre-initiation complex efficiently assembles on the uAUG111. We then wondered whether the ribosome assembled on this AUG codon proceeds to translation elongation resulting in a polypeptide synthesis encoded by the uORF. By performing sucrose gradient analysis, we detected polysome formation suggesting that efficient translation is occurring from uAUG111 (Figure 3—figure supplement 1B). Accordingly, mutation of uAUG111 drastically reduces the amount of polysomes and the formation of 48S complexes in the presence of GMP-PNP thereby corroborating that the translation is starting on uAUG111 (Figure 3—figure supplement 1B). In Hoxa3 5’UTR, the uORF starting from uAUG111 is extending through the full IRES. To check further whether the uORF is indeed translated through the full-length Hoxa3 5’UTR, we first deleted a single nucleotide (G333) to change the frame and thereby producing a fusion protein formed by the peptide produced from the uORF and RLuc. Indeed, with this single frameshifting point mutation, we could detect a longer protein demonstrating that the pre-initiation complex assembled on the uAUG111 indeed proceeds to translation elongation and is efficiently translating through the full-length 5’UTR of Hoxa3 mRNA (Figure 4A). We also verified the translation from uAUG111 with our reporter constructs containing only the Hoxa3 TIE. Likewise, the insertion of a single frameshifting nucleotide (A220) allows the detection of a longer fusion protein (Figure 4—figure supplement 1A). Remarkably, with a double mutant that combines the mutation of the uAUG111 to ACG with the (A220) insertion, a mixture of two proteins is detected, the fusion protein and the more abundant RLuc protein. Indeed, this confirms that the ribosome requires the uAUG111 but still able to recognize, although less efficiently, the AUG-like ACG as a start codon (Figure 4—figure supplement 1A). Similarly, when we use the native full-length Hoxa3 mRNA, we detect the Hoxa3 uORF protein of 9 KDa size (Figure 4—figure supplement 1B). Altogether, our cell-free translation assays demonstrate that Hoxa3 TIE translation is achieved by translation of an uORF that starts at AUG111 codon that extends through the whole Hoxa3 5’UTR. To confirm these results in vivo, we generated reporter constructs in the plasmid pmirGlo that contains TIEs upstream of Renilla luciferase (hRLuc). Values were normalized to that of control enhanced Firefly luciferase (luc2) to calculate the luciferase activity for each report (Figure 4B). As expected, wild-type Hoxa3 TIE blocks translation very efficiently in both HEK293T and C3H10T1/2 cells. When the uAUG111 is mutated to UAC, the inhibition is significantly affected in both HEK293T and C3H10T1/2 cells at respectively 57% and 45% compared to wild-type Hoxa3 TIE (Figure 4B). Although the inhibition is not fully abolished, these experiments confirmed that the codon AUG111 is critical for efficient translation inhibition in Hoxa3 in vivo.

Figure 3 with 1 supplement see all
Download asset Open asset
Upstream AUG111 in Hoxa3 translation inhibitory element (TIE) is essential for inhibition.

(A) Substitution mutations in uAUG111and uAUG123 to UAC in Hoxa3 TIE were performed. Constructs with the corresponding mutations were translated in rabbit reticulocyte lysate (RRL) and luciferase assay was performed to evaluate the effect of mutation on translation efficiency as previously described. **p<0.01 (t-test as compared to construct w/o TIE). n = 3. Experiments were performed in triplicates. (B) Toe printing analysis of ribosomal assembly on two mRNAs, Hoxa3 TIE Wt and the mutant of upstream (AUG/UAC)111. Initiation complexes were assembled in RRL extracts in the absence or presence of translation inhibitors: cycloheximide and GMP-PNP. Reaction samples were separated on 8% denaturing PAGE together with the appropriate sequencing ladder. Toe print positions were counted starting on the A + 1 of the AUG codon at +16 position. A, U, and G nucleotides of the start codon are marked by black dots. Full-length cDNAs are indicated by an arrow at the top of the gel.

Figure 4 with 1 supplement see all
Download asset Open asset
The uAUG111 in Hoxa3 translation inhibitory element (TIE) is translated through 5’UTR of Hoxa3.

(A) Three transcripts were used for this experiment: full-length 5’UTR of Hoxa3, a deletion mutant at nucleotide G333 in Hoxa3 internal ribosome entry site (IRES) and a control transcript without TIE. To test the translation of upstream open reading frame (uORF) in Hoxa3 TIE starting form uAUG111, a deletion of G in Hoxa3 IRES at position 333 was performed to create a longer uORF that is in the same frame as the ORF of Renilla luciferase to create an N-terminally extended luciferase. FLa3 mRNA was used as a control to correspond to the full-length Hoxa3 5’UTR (TIE + IRES). Transcripts were translated in vitro in rabbit reticulocyte lysate (RRL) and products were loaded on 10% SDS-PAGE in the presence of 35S-methionine. (B) In vivo luciferase assays in two embryonic cells lines: HEK293FT (left) and C3H10T1/2 (right). Reporter constructs in pmirGlo containing Hoxa3 TIE, u(AUG/UAC)111, and without TIE were transfected in the two indicated cell lines. Renilla luciferase expression was normalized to the control (w/o TIE), which was set to 100%. **p<0.01 (t-test as compared to empty plasmid [w/o TIE]). Experiments were performed in triplicates. n = 3.

Hoxa11 TIE-mediated inhibition is mediated by a stalled 80S ribosome

We next asked whether Hoxa11 TIE has a similar inhibitory mechanism. Deletion experiments suggested that critical elements were located in the region 139–216. We also found that Hoxa11 TIE contains two putative upstream AUGs at positions 84–86 and 159–161. Mutations of both AUG84 and AUG159 had no impact on translation inhibition (Figure 5A). According to our 2D model, a long GC-rich stable stem loop (SL) structure (ΔG = −25.00 kcal/mol) spans nucleotides 104–154 (Figure 2B). This long hairpin comprises 16 G-C base pairs that can putatively interfere with the progression of a pre-initiation scanning complex. To test the inhibitory efficiency of this stem loop, we transplanted it in a strictly cap-dependent reporter mRNA containing the 5’UTR of Hbb-b1 upstream of the luciferase coding sequence. The Hoxa11 SL was inserted in the middle of the 5’UTR. In this construct the first 25 nucleotides from the 5’ proximity are unfolded thereby ensuring proper access to the 5’ cap. Interestingly, the translation of this mRNA was significantly abolished showing that this SL on its own is sufficient to inhibit cap-dependent translation when transplanted in another mRNA (Figure 5—figure supplement 1). Strikingly, in Hoxa11 TIE, uAUG84 codon is located 19 nts upstream of the inhibiting SL. This distance is compatible with the assembly of a pre-initiation complex on uAUG84 without clashing with the SL. Moreover, the distance between the uAUG and the SL is optimal for favouring AUG recognition by scanning arrest of the pre-initiation complex forced by the SL. Importantly, the uAUG84 is immediately followed by a stop codon UAG87. The sequence context of the uAUG84 (A at −3 and U at +4) is suboptimal compared to the consensus Kozak sequence. This unique combination of start-stop codon upstream of SL structure raised the question of whether the ribosome is forced to recognize this uAUG despite a suboptimal Kozak context. To address this hypothesis, we mutated the stop codon UAG87 to UGG thereby creating an uORF. When the stop is mutated, a small peptide is produced from the translation of uAUG84 through 5’UTR, which we called Hoxa11 uORF (Figure 5B). This experiment demonstrates that uAUG84 is indeed efficiently used as a start codon despite its suboptimal sequence context. Unfortunately, the presence of the highly stable SL is not compatible with the toe printing assay. Indeed, premature RT arrests occur due to the presence of the highly stable SL, rendering the toe printing assay on TIE Hoxa11 impossible. Therefore, to further confirm that the ribosome is efficiently assembled on uAUG84, we performed sucrose gradient analysis with radiolabelled mRNAs. With wild-type Hoxa11 TIE, an 80S complex efficiently accumulates in the presence of cycloheximide as expected. However, an 80S complex is also detected without inhibitor indicating that the 80S complex is in fact a stalled ribosome (Figure 5C, Figure 5—figure supplement 2). The mutation of uAUG84 to UAC drastically reduces the amount of 80S complex; in contrast, mutation of uAUG159 to UAC does not affect 80S accumulation. This further confirms that the stalled 80S complex is indeed assembled on the uAUG84. Altogether, this data show that a stalled ribosome is indeed assembled on uAUG84 and the stalling is caused by the synergistic effect of a stop codon next to the AUG and a stable SL downstream of the start-stop of Hoxa11.

Figure 5 with 2 supplements see all
Download asset Open asset
A start-stop upstream open reading frame (uORF) in Hoxa11 translation inhibitory element (TIE) stalls an 80S upstream of a highly stable structure.

(A) Mutational analysis of uAUGs in Hoxa11 TIE. Three transcripts with AUG/UAC mutations were used: M1: (AUG/UAC)84 + (AUG/UAC)159, M2: (AUG/UAC)84, and M3: AUG/UAC159. Transcripts were translated in rabbit reticulocyte lysate (RRL) at 50 nM concentrations and the luciferase expression was normalized to the control (w/o TIE) as previously described. **p<0.01 (t-test as compared to construct w/o TIE). n = 3. Experiments were performed in triplicates. (B) A single substitution (A/G)88 mutation destroys the stop codon UAG87 to UGG in Hoxa11 TIE, Hoxa11 TIE wt, and control (w/o TIE) were also translated as references in RRL. Translation products were loaded on 15% SDS-PAGE. (C) Ribosomal pre-initiation complexes were assembled and analysed on 7–47% sucrose gradient with [alpha-32P]GTP-radiolabelled Hoxa11 TIE as well as the two mutants of uAUG/UAC at the previously indicated positions in the absence or presence of cycloheximide. Heavy fractions correspond to polysomes and lighter fractions correspond to free RNPs. The coloured sections corresponding to RNP, 48S, 80S, and polysomes have been assigned according the the OD254nm profiles (see also Figure supplement S6).

Mass spectrometry analysis pre-initiation complexes programmed by Hoxa3 and Hoxa11 TIE

To further characterize the two different modes of action employed by Hoxa3 and Hoxa11, we identified the factors specifically acting in such mechanisms. For that, we purified pre-initiation complexes programmed by Hoxa3 and Hoxa11 TIE suitable for mass spectrometry analysis. Briefly, ribosomes were assembled on chimeric biotinylated mRNA–DNA molecules and immobilized on streptavidin-coated beads after incubation with RRL in the presence of cycloheximide or GMP-PNP. Complexes were then eluted by DNase treatment as previously described (Chicher et al., 2015; Prongidi-Fix et al., 2013) and analysed by mass spectrometry. Three different mRNA constructs were used, Hoxa3 TIE upstream of 5’UTR Hbb-b1, Hoxa11 TIE upstream of 5’UTR Hbb-b1, and 5’UTR Hbb-b1 as a negative control. Comparison between the three mRNAs blocked with cycloheximide enabled the identification of specific factors interacting with each RNA (Figure 6). Interestingly, for Hoxa3 TIE, we identified a set of translation-related proteins. Among the strongest hits, we found eIF2D, a non-canonical GTP-independent initiation factor which has been shown to be involved in the initiation step on specific mRNAs (Dmitriev et al., 2010; Vaidya et al., 2017; Vasudevan et al., 2020), reinitiation on main ORF (Ahmed et al., 2018; Weisser et al., 2017), and recycling after translation termination (Skabkin et al., 2013; Skabkin et al., 2010; Young et al., 2018). Another interesting hit is methionine aminopeptidase MetAP1 which removes N-terminal methionine from nascent proteins in a co-translational manner (Varland et al., 2015).

Figure 6 with 1 supplement see all
Download asset Open asset
Distinct profiles for factors involved in translation inhibitory element (TIE)-mediated inhibition blocked with cycloheximide.

Mass spectrometry analysis of cycloheximide-blocked translation initiation complexes and on three transcripts: Hoxa3 TIE, Hoxa11 TIE placed upstream of 5’UTR of Hbb-b1, and the 5’UTR of Hbb-b1 (control). Graphical representation of proteomics data: protein log2 spectral count fold changes (on the x-axis) and the corresponding adjusted log10p-values (on the y-axis) are plotted in a pair-wise volcano plot. The significance thresholds are represented by a horizontal dashed line (p-value=1.25, negative binomial test with Benjamini–Hochberg adjustment) and two vertical dashed lines (−1.0-fold on the left and +1.0-fold on the right). Data points in the upper left and upper right quadrants indicate significant negative and positive changes in protein abundance. Protein names are labelled next to the off-centred spots and they are depicted according to the following colour code: red spots are significant hits and black are non-significant with <10 spectra. Data points are plotted based on the average spectral counts from triplicate analysis. Three profiles were produced by comparing the proteomics of two transcripts.

Other factors that are linked to translation have been selected such as the scanning factor eIF1A and its isoform eIF1A-X, eIF3a, arginyl- and leucyl-tRNA synthetases QARS and LARS, DEAD-box helicases DHX36 and DDX39B, elongation factor HBS1L, and RpL38 ribosomal protein. For Hoxa11 TIE, we identified different translation-related proteins among which are ASAP1, a GTPase activator protein, MetAP1, RpL38, Valyl-tRNA synthetase, and eIF3j, another subunit of initiation factor eIF3 usually dissociating at early stages of initiation to allow mRNA entry (Aylett et al., 2015; Fraser et al., 2007; Young and Guydosh, 2019), thereby unlikely to be present in initiation complexes. When comparing Hoxa3 TIE with Hoxa11 TIE, we could detect some initiation factors and translation-related proteins specific for Hoxa3 like eIF2D, eIF1A, eIF1A-X, eIF5B, LARS, DHX21, and HBS1L (Figure 6, Supplementary file 1). Interestingly, HBS1L is enriched in both Hoxa3 and Hoxa11 cycloheximide-blocked complexes. HBS1L is a member of translational GTPase family which transports Pelota to stalled ribosomes with an empty A-site or an mRNA-occupied A-site in a codon-independent manner (Lee et al., 2007; Shao et al., 2016; Shoemaker et al., 2010). Another interesting hit is eIF5B, a factor whichcatalyses the joining of the large ribosomal subunit independently of its GTPase activity (Wang et al., 2019). The GTPase activity is only required for eIF5B release from the assembled 80S and thereby allows to proceed to elongation. EIF5B assists the correct positioning of Met-tRNAMet in the P-site (Wang et al., 2020). Interestingly, RpL38 protein is enriched in both TIE-programmed complexes. In fact, all the ribosomal proteins are present in the purified complexes (Figure 6, Supplementary file 1) so this enrichment might be due to free RpL38 outside of the ribosome particle. This is particularly interesting because RpL38 is involved for Hox IRES elements (Xue et al., 2015). Altogether, these results show a variation in the translation factors involved which hints two distinct TIE-mediated inhibitions.

Similarly, we purified programmed pre-initiation complexes blocked by GMP-PNP (Figure 6—figure supplement 1, Supplementary file 2). By comparing Hoxa3 to either Hbb-b1 or Hoxa11 mRNAs, we also found an enrichment of eIF2D as Hoxa3-specific factor. Interestingly, we also found an enrichment of PKR protein (also called eIF2AK2) for both Hoxa3 and Hoxa11 (Figure 6—figure supplement 1). PKR is known to bind double-stranded RNA during viral infection which mediates its auto-activation and induces the phosphorylation of eIF2α subunit (Adomavicius et al., 2019). This leads to the inhibition of mRNA translation. The enrichment of both eIF2D and PKR for Hoxa3 raised the question of whether eIF2D is indeed mediating the translation of uORF by an alternative mechanism. To address this hypothesis and the involvement of eIF2D, we conducted a set of in vivo experiments.

Translation inhibition by TIE requires eIF2D

After specifically identifying eIF2D by mass spectrometry analysis for Hoxa3 TIE-ribosomal complex, we were interested in getting more insights into how this factor might be involved. Previous studies have shown that eIF2D is a non-canonical translation initiation factor which delivers tRNA to the P-site of the ribosome in a GTP-independent manner (Dmitriev et al., 2010). It has been shown to be involved in the initiation step on specific mRNAs (Dmitriev et al., 2010; Vaidya et al., 2017; Vasudevan et al., 2020), reinitiation on main ORF (Ahmed et al., 2018; Weisser et al., 2017). Additionally, other studies showed that eIF2D is required for recycling after translation termination (Skabkin et al., 2013; Skabkin et al., 2010; Young et al., 2018). To confirm the involvement of eIF2D in Hoxa3 TIE-mediated inhibition mechanism, we performed a co-transfection assay in HEK293T cell line using siRNA against either eIF2D or non-target pool of siRNAs (siRNA-NT) together with a reporter plasmid harbouring Hoxa3 TIE. The plasmid used harbours two reporter genes, RLuc to test the impact of TIEs and Firefly luciferase for normalization purposes (Figure 7A). As a control, we used reporter plasmids with Hoxa11 TIE and the same plasmid without TIE. After 48 hr incubation, cells were lysed for western blot analysis and luciferase assay (Figure 7A). For normalization, RLuc values were compared to that of Firefly luciferase (RL/FL) in each construct. To determine the effect of eIF2D silencing, the RL/FL ratio was compared to that with the siRNA-NT, which serves as a control for siRNA effect on the cell line. Thereby, the comparison between the two values would determine the effect of eIF2D silencing with each TIE. Interestingly, silencing eIF2D in Hoxa3-transfected cells at an efficiency of 76% drastically abolishes Hoxa3-mediated inhibition and RL/FL ratio (0.06) increases six times compared to that in siRNA-NT cells (0.01) (Figure 7A). On the contrary, the silencing of eIF2D at efficiency of 81% has no significant effect on Hoxa11-mediated inhibition (RL/FL ratio of 0.02 with both siRNAs). Similarly, silencing eIF2D at 83% efficiency has no effect on general translation (RL/FL ratio remains around 0.06 with both siRNAs). Altogether, this confirms the specific requirement of eIF2D for efficient Hoxa3 inhibition but not for Hoxa11. This conclusion is in good agreement with our previous mass spectrometry analysis of Hoxa3-ribosomal complexes blocked by translation inhibitors, which show the specific presence of eIF2D in the initiation complexes programmed with Hoxa3 TIE (Figure 6, Figure 6—figure supplement 1). The fact that we found eIF2D in pre-initiation complexes suggests that eIF2D is involved in the initiation of Hoxa3 uORF. Since Hoxa3 uORF is long and extends downstream the AUG start codon of the main CDS in native Hoxa3 mRNA, which means that the Hoxa3 uORF partially overlaps the main CDS, a mechanism using a reinitiation event after Hoxa3 uORF translation is impossible. Therefore, we rather favour a model in which eIF2D is required for Hoxa3 initiation. Previous studies have shown that an A-motif upstream of an uAUG has been shown to be important for proper eIF2D recruitment (Dmitriev et al., 2010). Interestingly, a closer look at the sequences in the Hoxa3 TIE uORF revealed A-rich motifs upstream and downstream of uAUG111. We tested the implication of both A-motifs, AAAA107 upstream of the AUG and AAAAA147 downstream of the AUG, in Hoxa3 TIE-mediated inhibition (Figure 7B). In order to avoid any side effect due to mutation in the sequence context around the uAUG, we kept an optimal Kozak sequence and mutated the As at position 107–110 to GGCC thereby keeping a purine residue at −3 position. The second A-motif downstream of AUG was similarly mutated to GGCCC. Interestingly, the mutation of upstream A-motif had a twofold reduction effect on translation inhibition of Hoxa3 TIE. In contrast, mutation of the downstream A-motif does not affect Hoxa3TIE inhibition (Figure 7B). Additionally, we confirmed the implication of upstream A-motif in vivo with HEK293T cell line using plasmids with wild-type Hoxa3 and the mutant of AAAA107 into GGCC (Figure 7B). The AAAA107 mutant reduces the inhibitory efficiency of Hoxa3 TIE by 2.5 times compared to wild-type Hoxa3. Therefore, we show that the A-motif upstream of the AUG is critical for translation inhibition and most probably because it is required for eIF2D recruitment.

Figure 7
Download asset Open asset
Co-transfection assay of translation inhibitory element (TIE) plasmids and siRNA against eIF2D confirms its implication in Hoxa3-mediated inhibition.

Mutational analysis of A-motif sequences in Hoxa3 TIE shows a requirement for an upstream A-motif for efficient inhibition. (A) Co-transfection assay was performed using pmirGLO plasmids with inserts of Hoxa3 TIE, Hoxa11 TIE, and w/o TIE (pmirGLO) with siRNA against eIF2D (siRNA-eIF2D), and non-target pool of siRNA (siRNA-NT) in HEK293 cell line. The plasmids harbour two reporter genes, Renilla luciferase for monitoring the impact of TIEs and Firefly luciferase for normalization. Plates were incubated for 48 hr followed by cell lysis. Cell lysate was analysed by western blot and luciferase assay. The histograms present the Renilla to Firelfly luciferase activity ratio. **p<0.01 (t-test as compared to construct w/o TIE). n = 3. Experiments were performed in triplicates. Efficiency of silencing of each protein was quantified by western blot analysis for Hoxa3 TIE and Hoxa11 TIE samples. (B) Two sets of mutations were performed on distinct A-motif sequences in Hoxa3 TIE. The first mutation is AAAA/GGCC107 and the second mutation AAAAA/GGCCC147. The transcripts were in vitro translated in RRL with Hoxa3 TIE Wt and control (w/o TIE). Results were confirmed in vivo in HEK293FT cell line. Luciferase activities were normalized to control (w/o TIE). **p<0.01 (t-test as compared to construct w/o TIE). n = 3. Experiments were performed in triplicates.

Discussion

Our study has shown that two HoxA mRNAs, Hoxa3 and Hoxa11, are regulated by different mechanisms to ensure the inhibition of cap-dependent translation and allowed us to propose two distinct models for their mode of action (Figure 8). First, we have shown that TIEs can function in vitro using cell-free translation extracts. We then confirmed the results obtained with these extracts using in vivo assays in several cell lines. Our findings suggest that Hoxa3 inhibits translation by an uORF which is translated through the whole 5’UTR of Hoxa3 mRNA producing a small protein of size 9 KDa. Interestingly, the alignment of Hoxa3 TIE shows a conservation of the uAUG111 (highlighted in red box) among different species. In contrast to the localization of the uAUG that is highly conserved, the coding sequence of the uORF is not conserved among species (Figure 8—figure supplement 1A). Indeed, uORFs have been recognized as regulators of translation for number of cellular mRNAs (Barbosa et al., 2013). For instance, four uORFs in the 5’ leader of yeast GCN4 mRNA restrict the flow of scanning ribosomes from the cap site to the GCN4 initiation codon (Dever et al., 2016; Hinnebusch, 1993). In plants, the uORF in AdoMetDC mRNA generates a nascent hexapeptide that interacts with its translating ribosome to suppress translation of AdoMetDC RNA in a cell-specific manner (Uchiyama-Kadokura et al., 2014). Interestingly, our data indicates that eIF2D is required in Hoxa3 TIE mode of action (Figure 6 and 7A). A recent study has shown that Drosophila ATF4 mRNA translation is induced by eIF2D and its homologue DENR during integrated stress response (Vasudevan et al., 2020). In this case, eIF2D requires its RNA binding motif to mediate translation of ATF4 mRNA through its 5’ leader sequence consisting of multiple uORFs (Vasudevan et al., 2020). Moreover, it has been shown that eIF2α phosphorylation during stages of embryonic development promotes translation from uORFs (Friend et al., 2015). Therefore, canonical cap-dependent translation initiation with eIF2 is not possible during embryonic development. The cap-dependent translation initiation of uORF from Hoxa3 TIE might use eIF2D as an alternative to replace inactive phosphorylated eIF2 to promote uORF translation. So far, the only cis-acting sequence that has been clearly defined on an mRNA for specific eIF2D recruitment is an A-rich motif upstream of the start codon (Dmitriev et al., 2010). We showed that Hoxa3 TIE contains such an A-motif upstream of the uORF that is critical for TIE function (Figure 7). Other reports showed that eIF2D would form initiation complexes on leaderless and A-rich 5’UTRs (Akulich et al., 2016; Dmitriev et al., 2010). In Hoxa3 TIE, mass spectrometry analysis enabled us to demonstrate that eIF2D is present only in pre-initiation complexes programmed with Hoxa3 TIE. Importantly, two more factors, eIF5B and HBS1L, have been specifically found in Hoxa3 complexes, which would be interesting to investigate their involvement in eIF2D-dependent mechanism (Figure 6). Regarding Hoxa11 TIE, the ribosome recognizes a combination of two cis-acting elements in the 5’UTR (Figure 8). (i) A start-stop codon combination located at positions 84–89 and (ii) a long highly stable GC-rich helical structure (SL) located at +20 downstream of the uAUG (by convention, the A from the AUG being +1). These two elements act in synergy to promote the stalling of an 80S complex upstream of the SL. This is a reminiscent of a similar mechanism that has been described in the Arabidopsis thaliana NIP5.1 5’UTR mRNA that contains an AUG-stop that regulates translation of the main ORF through a ribosome stalling mechanism and mRNA degradation (Tanaka et al., 2016). This mechanism requires only the start-stop codons. In the case of Hoxa11 TIE, the stable SL structure that is present downstream of the AUG-stop plays a major role. A ribosome that is stalled with a stop codon in the A-site, in other words an empty A-site without any tRNA, is usually the signal for recruitment of the release factors to dissociate the ribosomal subunits from the mRNA. With our cell-free translation assay and sucrose gradient analysis, we showed that the stalled 80S programmed with Hoxa11 TIE is very stable and does not dissociate (Figure 5C). A possible explanation for the stability of this complex could be that the SL blocks the access of the release factors to the empty A-site thereby preventing ribosome dissociation (Brown et al., 2015). Interestingly, the alignment of Hoxa11 TIE among different species shows that the start-stop combination (highlighted in red) lacks conservation and remains species-specific (Figure 8—figure supplement 1B). Some species possess a substitution of the start codon AUG to AUG-like codons such as GUG or a mutation of stop codon that leads to a longer uORF. In contrast, the SL (104–154) remains highly conserved suggesting its high functional significance (Figure 8—figure supplement 1B). Accordingly, we have shown that the sole SL is strong enough to impede scanning by the pre-initiation complex. Indeed, secondary structures in the 5’UTR have been shown to inhibit translation like the case of a conserved SL structure in the 5’UTR of TGF-β1 mRNA (Jenkins et al., 2010). Therefore, in various species, Hoxa11 TIE might use different combinations of cis-acting elements in order to block cap-dependent translation, the common cis-acting element between all species being the SL that is conserved.

Figure 8 with 1 supplement see all
Download asset Open asset
Two distinct models for translational inhibition by Hoxa3 translation inhibitory element (TIE) and Hoxa11 TIE.

A model for Hoxa3 TIE suggests a ribosomal assembly on the uAUG111 with a requirement of eIF2D initiation factor. The model for Hoxa11 TIE suggests a stalled 80S ribosome on AUG-stop codons combination upstream of a highly stable structure.

As previously described, the Hoxa11 IRES requires the presence of the ribosomal protein RpL38 while Hoxa3 IRES is RpL38-independent (Kondrashov et al., 2011). Our probing experiments revealed that the folding of both Hoxa3 and Hoxa11 TIEs is independent of the presence of IRES suggesting that their mode of action does not depend on the IRES. TIE may have evolved in such a way to favour the translation from the downstream IRES hence justifying why there is variation in terms of sequence and mechanism but same inhibitory effect. This unique combination of an inhibitor of canonical translation mechanism and the activator of specialized translation sets an interesting point on how the 5’UTR elements confer ribosome specificity to translation (Xue et al., 2015). Importantly, the acquisition of these TIEs in subsets of Hox mRNAs enables an additional layer of regulatory control between the canonical translation and the IRES-dependent one. One intriguing study would be to determine how other TIEs a4 and a9 inhibit translation and whether there are common functional features amongst all Hox mRNAs. Beyond Hox mRNAs, our data on eIF2D suggests a specific role in translation initiation and it would be interesting to decipher its precise role at the molecular level. More precisely, investigations that will allow determining how uORF length, codon composition, and consensus sequences may influence the role of eIF2D in the initiation process on uORFs are needed. Future studies will be required to fully understand the role of eIF2D in translation initiation of specific mRNAs.

Materials and methods

Plasmids

For in vitro studies, murine Hoxa3 TIE (170 nts) and Hoxa11 TIE (216 nts) (sequences were kindly provided by Dr Maria Barna, which were amplified from mouse E10.5–12.5 cDNA; Xue et al., 2015) were placed upstream of 5’UTR of Hbb-b1 (accession number: KU350152) (50 nts) and Renilla reniformis luciferase coding sequence (accession number: M63501) (936 nts). These constructs were cloned in pUC19 vector in the HindIII site, then used as a template for further PCR amplifications and site-directed mutagenesis.

For in vivo studies, we introduced an EcoRI restriction site upstream of hRLuc-neo fusion sequence in pmirGLO vector (Promega) using Quick Change site-directed mutagenesis kit II XL (Thermo Fischer Scientific). Subsequent cloning experiments of Hoxa3 TIE, Hoxa11 TIE, and their mutants were performed in pmirGLO vector at EcoRI site using NEBuilder HiFi DNA Assembly kit. All clones were checked by sequencing.

Cell lines

Request a detailed protocol

Two cell lines were used for our in vivo assays: human embryonic kidney cell line HEK293FT (ATCC) purchased from Invitrogen (ref R700-07) and murine mesenchymal stem cell line C3H10T1/2 (clone 8, ATCC CCL26). HEK293FT cells were cultured in Dulbecco’s modified eagle medium (DMEM) with 2 mM of L-glutamine and 10% fetal bovine serum (FBS) supplemented with 100 units/ml of penicillin/streptomycin. Subcultures were performed after trypsin-EDTA treatment for dissociation at sub-confluent conditions (70–80%) 1:4 to 1:10 seeding at 2–4·104 cells/cm2 according to manufacturer’s instructions. C3H10T1/2 cells were cultured in basal DMEM supplemented with 2 mM glutamine, 1.5 g/l sodium bicarbonate, and 10% FBS supplemented with 40 μg/ml gentamicine. Subcultures were performed after trypsin-EDTA treatment for dissociation at sub-confluent conditions (60–70%). Seeding dilutions were performed at 2000 cells/cm2 one time per week.

RNA transcription

Request a detailed protocol

Transcription templates were generated by PCR amplification from the plasmids pUC19-TIE. The amplified templates were used for in vitro transcription with recombinant T7 RNA polymerase in the presence of either m7GpppG cap analogue or non-functional cap analogue ApppG (New England Biolabs). To check RNA integrity, an aliquot was mixed with formamide dye and loaded on 4% denaturing polyacrylamide gel. The RNA was visualized under UV light after ethidium bromide staining. To eliminate unincorporated nucleotides, the RNA sample was loaded on a gel filtration Sephadex G25-column (Pharmacia Fine Chemicals), proteins were then eliminated by phenol extraction, and the RNA transcripts were precipitated with 0.25 M NaCl in ethanol. After centrifugation, RNA pellets were dried and resuspended in autoclaved milli-Q water. The concentration of purified RNA samples was determined by absorbance measurement at 260 nm.

In vitro translation assays in cell-free translation extracts

Request a detailed protocol

In vitro translation was carried out using increasing concentrations of mRNA transcripts with self-made untreated RRL, amino acid mixture containing all the amino acids except methionine (1 mM of each), RNasin (Promega ), 75 mM KCl, 0.5 mM MgCl2, 3.8 mCi [35S] methionine, and autoclaved milli-Q water. Reaction mixture was incubated at 30°C for 1 hr. Aliquots of translation mixture were analysed by SDS-PAGE (10%) (Laemmli, 1970) and translation products were visualized by phosphor imaging. In vitro translation assays with wheat germ extract (Promega) were performed according to manufacturer’s instructions. In vitro translation assays with HeLa cell extract and Drosophila S2 cell extract were performed as previously described (Thoma et al., 2004; Wakiyama et al., 2006).

Chemical probing

Probing experiments were performed as previously described (Alghoul et al., 2021). 

Probing with DMS

Request a detailed protocol

Modification by DMS was performed on 2 pmoles of each RNA (Hoxa3 TIE and Hoxa11 TIE). The RNA is first incubated for 15 min in DMS buffer (50 mM Na cacodylate [pH 7.5], 5 mM MgCl2, and 100 mM KCl) and 1 μg of yeast total tRNA (Sigma- Aldrich) and then modified with 1.25% DMS reagent (diluted with ethanol 100%) with 10 min incubation at 20°C and stopped on ice. Modified transcripts were precipitated with 0.25 M NaCl, 0.1 mg/ml glycogen in ethanol. RNA pellets were dried and resuspended in autoclaved milli-Q water. Modified nucleotides were detected by primer extension arrests that were quantified. The intensity of the RT stops is proportional to the reactivity for each nucleotide.

Probing with CMCT

Request a detailed protocol

Similarly, modification by CMCT was performed on 2 pmoles of each RNA (Hoxa3 TIE and Hoxa11 TIE). Each RNA is incubated for 20 min in CMCT buffer (50 mM Na borate [pH 8.5]; 5 mM MgCl2; 100 mM KCl) and 1 μg of yeast total tRNA. Then modifications were performed with 10.5 g/l CMCT reagent with 20 min incubation at 20°C and stopped on ice. Modified transcripts were precipitated with 0.25 M NaCl, 0.1 mg/ml glycogen in ethanol. RNA pellets were dried and resuspended in autoclaved milli-Q water. Modified nucleotides were detected by primer extension arrests that were quantified. The intensity of the RT arrests is proportional to the reactivity for each nucleotide.

Primer extension

Request a detailed protocol

RT was carried out in a 20 μl reaction with 2 pmoles of RNA and 0.9 pmoles of 5’ fluorescently labelled primers. We used fluorescent Vic and Ned primers (Thermo Fischer Scientific) of same sequence for all RT reactions which are complementary to the Hbb-b1 5’UTR from nucleotides 6–37:

5’-GGTTGCTAGTGAACACAGTTGTGTCAGAAGC-3’.

First, the RNA was unfolded by a denaturation step at 95°C for 2 min. Then, fluorescent primers were annealed for 2 min at 65°C followed by incubation on ice for 2 min. Samples were incubated in a buffer containing 83 mM KCl, 56 mM Tris-HCl (pH 8.3), 0.56 mM each of the four deoxynucleotides (dNTP), 5.6 mM DTT, and 3 mM MgCl2. RT was performed with 1 unit of avian myoblastosis virus (AMV) reverse transcriptase (Promega) at 42°C for 2 min, 50°C for 30 min, and finally 65°C for 5 min. In parallel, sequencing reactions were performed in similar conditions, but supplemented with 0.5 mM dideoxythymidine or dideoxycitidine triphosphate (ddTTP or ddCTP) (protocol adapted from Gross et al., 2017). The synthesized cDNA were phenol–chloroform extracted and precipitated. After centrifugation, the cDNA pellets were washed, dried, and resuspended in 10 μl deionized Hi-Di formamide (freshly prepared highly deionized formamide). Samples were loaded on a 96-well plate for sequencing on an Applied Biosystems 3130xl genetic analyser. The resulting electropherograms were analysed using QuSHAPE software (Karabiber et al., 2013), which aligns signal within and across capillaries, as well as to the dideoxy references of nucleotide at specific position and corrects for signal decay. Normalized reactivities range from 0 to 2, with 1.0–2.0 being the range of highly reactive positions. A preliminary secondary structure model was first initiated by mfold (Mathews et al., 2016) and then edited according to reactivity values.

Sucrose gradient analysis

Request a detailed protocol

To analyse the assembly of ribosomal pre-initiation complexes on the RNA of interest, the complexes were loaded on 7–47% sucrose gradients containing 5 mM MgCl2, 25 mM Tris-HCl (pH 7.5), 1 mM DTT, and 50 mM KCl. We used the specific translation inhibitors GMP-PNP (4 mM), cycloheximide (1 mg/ml), geneticin (0.7 mM), hygromycin (0.5 mg/ml), and edeine (10 mM), they were added to the RRL with a mix containing the 20 amino acids at 1.5 mM each, RNasin (Promega), 35 mM KCl, and 0.24 or 2.4 mM MgCl2, prior to incubation with the 5’ capped radioactive mRNA of interest. The assembled pre-initiation complexes were formed by incubation in RRL at 30°C for 5 min. Then, 8 mM MgAc2 was added and one volume of 7% sucrose. Samples were then layered on the surface of 11 ml 7–47% sucrose gradient and centrifuged for 2 hr 30 min in an SW41 rotor at 37,000 rpm at 4°C. After centrifugation, the whole gradient was fractionated, and the mRNA was localized by measuring radioactivity in each collected fraction by Cerenkov counting in a scintillation counter.

Mass spectrometry and data processing

Request a detailed protocol

Protein extracts were digested with sequencing-grade trypsin (Promega) as previously described (Chicher et al., 2015; Prongidi-Fix et al., 2013). Peptide digests were analysed by nano LC-MS/MS and MS data were searched by the Mascot algorithm against the UniProtKB database from Oryctolagus cuniculus (rabbit). Identifications were validated with a protein false discovery rate of less than 1% using a decoy database strategy. The total number of MS/MS fragmentation spectra was used to quantify each protein from three independent biological replicates. This spectral count was submitted to a negative -binomial test using an edge R GLM regression through the R-package. For each identified protein, an adjusted p-value corrected by Benjamini–Hochberg was calculated, as well as a protein fold change (FC is the ratio of the average of spectral counts from a specific complex divided by the average of spectral counts from a reference protein complex). The results were presented in a volcano plot using protein log2 FC and their corresponding adjusted log10p-values. The proteins that were up-regulated in each condition are shown in red (Hoxa3 TIE versus Hbb-b1 mRNA, Hoxa11 TIE versus Hbb-b1 mRNA, and Hoxa3 TIE versus Hoxa11 TIE).

In vivo luciferase assay

Request a detailed protocol

For in vivo luciferase assay, HEK293T cells and C3H10T1/2 cells were transfected in six-well plates with various constructs of pmirGlo vector (Promega). Transfection was performed using Turbofect transfection reagent (Thermo Fischer Scientific) according to manufacturer’s instructions. Cells were collected 24 hr post-transfection. Luciferase assay was performed using Dual-Glo luciferase kit (Promega) according to manufacturer’s instructions. Firefly luciferase activities were measured to monitor transfection efficiency in order to normalize RLuc activities for each construct.

Co-transfection assay of siRNAs and reporter plasmid in HEK293T cells

Request a detailed protocol

HEK293FT cells were used to test the effect on inhibition of eIF2D knock-down and of a non-target siRNA pool, as a negative control, on RLuc expression (hRluc-neo) in pmirGLO vectors. We used ON-TARGETplus human siRNAs against eIF2D (catalog number L-003680-01-00) and siRNA-NT (catalog number D-001810-10-05) purchased from Horizon Discovery. HEK293T cells were cultured according to manufacturer’s instructions (ATCC) for 24 hr and used for co-transfection by siRNAs and reporter plasmid. We used 2 × 105 cells in 1 ml of culture medium without antibiotics. Upon reaching 70% confluence, cells were transfected by 5 pmoles of siRNAs in different wells with 500 ng of reporter plasmid. Transfections were performed with Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. After 48 hr, cells were washed twice by phosphate buffered saline (PBS 1×) and incubated with passive lysis buffer 1× for 15 min. Luciferase assay was performed according to manufacturer’s instructions. Protein concentration was measured by Bradford’s assay. The impact of silencing on TIE-mediated translation inhibition was measured by luciferase assay according to manufacturer’s instructions as previously mentioned.

Western blot against eIF2D and GAPDH

Request a detailed protocol

The silencing efficiency was quantified by western blots using rabbit polyclonal anti-eIF2D antibody (12840–1-AP) from Proteintech and mouse polyclonal anti-GAPDH antibody (sc-1377179) from Santa Cruz Biotechnology. For that, 20 μg of protein extracts were loaded on 10% polyacrylamide SDS-PAGE. After migration, proteins were transferred to an Immobilin-P membrane (Millipore) at 10 V for 1 hr in a semi-dry apparatus (Trans-Blot SD) on a PVDF (polyvinylidene fluoride) membrane that had been previously activated with 100% methanol for few seconds and a transfer buffer pH 8 (25 mM Tris; 200 mM glycine; 20% ethanol). After transfer, the membrane was saturated for 2 hr by blocking buffer (5% milk, 0.05% Tween-20, PBS 1×). Primary antibodies were added at dilutions recommended by the manufacturers in blocking buffer, the membranes were incubated overnight at 4°C. Then, the membranes were washed three times by PBST (PBS 1×; 0.05% Tween-20) to remove the excess of primary antibodies. Then, membranes were incubated with secondary HRP-conjugated antibody for 1 hr at room temperature followed by three washing steps. The signal produced by reaction between HRP and ECL (Kit ECL Plus Western Blotting Detection System, GE Healthcare) was detected by chemiluminescence using imaging Chemidoc (Biorad).

Ribosome toe printing assay

Request a detailed protocol

Toe printing assay was adapted from previously established protocols (Martin et al., 2016; Martin et al., 2011). Briefly, RRLs were incubated for 5 min at 30°C then 10 min on ice with buffer containing 1 U/μl of recombinant RNasin (Promega), 75 mM KCl 0.5 mM MgCl2, and 1.3 mM of puromycin prior to initiation complex assembly. Then, the pre-initiation complexes were formed by incubation with 500 nM of the RNA of interest in the presence of specific inhibitors such as cycloheximide (1 mg/ml) or GMP-PNP (4 mM) for 5 min at 30°C and then 20 min on ice. Then, the pre-initiation complexes were complemented with one volume of ice-cold buffer A containing 20 mM Tris-HCl (pH 7.5), 100 mM KAc, 2.5 mM MgAc2, 2 mM DTT, 1 mM ATP, and 0.25 mM spermidine and placed on ice. In order to separate ribosomal complexes from the non-ribosomal fraction, samples were centrifuged at 88,000 rpm in S100AT3 rotor (Sorvall-Hitachi) at 4°C for 1 hr. After centrifugation, the pellets containing the pre-initiation complexes were resuspended in 30 μl of ice-cold buffer A and incubated with 5’ radioactively labelled DNA oligonucleotide complementary to nts 22–51 of RLuc coding sequence for 3 min at 30°C. Then, 1 μl of a 320 mM Mg(Ac)2, 4 μl of a dNTP mixture (containing 5 mM of dATP, dGTP, dTTP, and dCTP), 10 units of recombinant RNAsin (Promega), and 1 unit/μl AMV reverse transcriptase (Promega) were added and incubated for 1 hr at 30°C. The synthesized cDNAs were analysed on 8% PAGE next to sequencing ladders.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been deposited on DRYAD: DOI https://doi.org/10.5061/dryad.j3tx95xdg.

The following data sets were generated
    1. Alghoul F
    2. Schaeffer L
    3. Eriani G
    4. Martin F
    (2021) Dryad Digital Repository
    Translation Inhibitory Elements from Hoxa3 and Hoxa11 mRNAs use uORFs for translation inhibition.
    https://doi.org/10.5061/dryad.j3tx95xdg

References

Decision letter

  1. Nahum Sonenberg
    Reviewing Editor; McGill University, Canada
  2. James L Manley
    Senior Editor; Columbia University, United States

Our editorial process produces two outputs: i) public reviews designed to be posted alongside the preprint for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.

Acceptance summary:

Homeobox (Hox) genes encode many mRNAs whose expression is controlled at the level of translation via translation inhibitory elements (TIE) that impair cap-dependent translation. The paper reports that the translation of Hox a3 and a11 is regulated by different mechanisms. The inhibitory mechanism that is mediated by TIE a3 requires the translation initiation factor eIF2D, while The inhibitory mechanism of TIE a11 is mediated by three elements: an upstream start codon (uAUG), followed by a stop codon, and a long stable hairpin. These findings show that the TIE elements of Hox mRNAs control translation via novel mechanisms.

Decision letter after peer review:

Thank you for submitting your article "Translation Inhibitory Elements from Hox a3 and a11 mRNAs use uORFs for translation inhibition" for consideration by eLife. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and James Manley as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.

Given the importance of HoxA mRNAs in development the paper is of interest. The study is comprehensive and thorough. A revised version needs to address the listed below criticisms and concerns. The full text of the reviewers' comments is appended, inasmuch as they contain many additional thoughtful and constructive criticisms.

1. The mass spectral tables must be shown. Also, some validation of at least some of the data is necessary (reviewer #2).

2. The ribosome binding assays are problematic and need to be rectified (reviewer #2). Reviewer #1 raised issues with peak/fraction assignments.

3. Figure 7A (reviewer #1). It is not clear why is it expected that reduction in eIF4E levels would interfere with TIE-mediated inhibition on translation. Also, internal controls, which are known to be (or not be) responsive to eIF4E and eIF2D suppression are lacking making it difficult to judge whether the changes in expression are specific.

4. It is not clear why specifically Hox a3 and a11 were investigated, and not the other HoxA mRNAs (reviewer #3).

5. Figure 6 (reviewer#3), both TIE a3 and a11 are showing RPL38 ribosomal protein. Why is it stated on page 38 that Hox a3 mRNA is RPL38-independent?

6. In vitro and cell-based experiments assessing the translational activity of reporters lack internal reference controls. What is usually used in these types of experiments is an IRES-driven reporter that can inform on non-specific inhibition events and control for transfection efficiencies

7. The paper is too long.

Reviewer #1 (Recommendations for the authors):

There are many instances (in other contexts) where uORFs or secondary structure within 5' UTRs have been found to be detrimental to translation initiation. Whereas the current study provides insight into the specific regulation of the Hox a3 and Hox a11 mRNAs, the mechanism elucidated is not particularly novel.

1. In vitro and cell-based experiments assessing the translational activity of reporters lack internal reference controls (unless I am missing something on how the data was processed). What is usually used in these types of experiments is an IRES-driven reporter that can inform on non-specific inhibition events and control for transfection efficiencies. As well, the authors have not ruled out differential mRNA stabilities contributing to reduced output from test mRNAs in any of their experiments.

2. FiguresS3B, 5C and 8 – In this ribosome binding assay, we do not see the distribution of the ribosomes throughout the gradient, only the radiolabelled counts of the mRNA are plotted as % of input. How do the authors know to assign polysomes, 80S, 48S, RNP to specific parts of the gradient? I'm assuming they are using the migration of their labelled mRNA in the presence of drugs whose mechanism of action are known to infer there the polysomes, 80S, 48S, RNP are located, but this is indirect. Normally, when these polysome binding studies are understaken, one monitors the OD260 profile to directly observe the ribosome distribution throughout the gradient. The mRNA counts are then layered on top of this.

3. The authors undertake Mass Spect analysis of pre-initiation complexes purified by affinity chromatography and report differences in protein-RNA complexes when complexes were formed on TIE a3 versus TIE a11 globin mRNA. I couldnt really get a sense of how well the purification worked, on the quality of the MS data, nor could I find comprehensive experimental validation performed on several of the "hits". The authors refer to eIF2D (as well as eIF1A, eIF1a-X, eIF5B, LARS, QARS, DHX21, HBS1L [p. 16]) as TIE a3 enriched factors and make the statement that this hints at two distinct TIE-mediated inhibitions. I disagree with this statement since factors, such as eIF5B, eIF1A, LARS, QARS, are required for the basic translation process and their presence will simply reflect which stage of translation is captured/enriched in the affinity chromatography experiments. I think this preliminary data is over-interpreted in its current form. Since PKR appears in the a3 and a11 complexes, is eIF2alpha phosphorylated in cells expressing these reporters?

4. The labelling on siRNA-eIF2D panel for TIE a3 in Figure 7 should be better positioned above the panel.

5. I don't understand the results with si4E in Figure 7A. Why is it expected that reduction in eIF4E levels would interfere with TIE-mediated inhibition on translation? As well, internal controls known to be (or not be) responsive to eIF4E and eIF2D suppression are lacking here in order to be able to know if changes in expression are specific.

6. I'm not sure the cycloheximide experiment in Figure 8 adds to the understanding of the a3 TIE. It's not that complexes are "resistant" to cycloheximide (as the authors state in their subtitle), it's just that different complexes are observed compared to the reporter without the TIE 5' UTR. Without knowing the basis for these additional complexes, or their composition, this experiment is of limited value since a clear interpretation is difficult to make.

Reviewer #2 (Recommendations for the authors):

1. The tables for the mass spectrometry experiments were not included. These should be added.

2. Based on the data presented, it seems the authors are overemphasizing the "start-stop" part of the mechanism for a11. A better wording would note the generality of the SL for a11, and a species-specific use of a "start-stop" uORF upstream of the SL.

3. All of the data points for the bar graphs should be plotted on top of the bars.

Reviewer #3 (Recommendations for the authors):

1. There are 9 figures in the manuscript that should be consolidated, as it is cumbersome for the reader to follow.

2. What is the relation between Hox and the Drosophila genes Antp and Ubx? This is not clear in the Introduction section.

3. It is not clear why specifically Hox a3 and a11 were investigated, and not the other HoxA mRNAs.

4. The grammar of manuscript needs correction, and many sentences are missing appropriate punctuation which adds to confusion

5. The term in vivo refers to research done with or within an entire living organism. The term in vitro refers to research done outside of a living organism, this included studying cells in culture. The term in vivo should be corrected in the manuscript. OR better yet, don't use either term because they are context dependent.

6. The mutations performed in AUG123 from Figure S3A (right panel) are not described in the manuscript.

7. What does FLa3 stand for in Figure 4A?

8. Why does Figure S4B (right panel) have two lanes for Hox a3 and w/o TIE? Are they representing duplicate results? The lanes should be labeled.

9. Are the results from Figure S5 statistically significant?

10. Figure 6 (middle panel) is not showing QARS, as mentioned in the manuscript on page 16, line 8.

11. Figure 6, both TIE a3 and a11 are showing RPL38 ribosomal protein. Why does page 38 states that Hox a3 mRNA is RPL38-independent?

12. Page 17 lines 1-5, the percentage mentioned of 74% and 76% are respectively to Hox a3 and a11? This should be clarified.

13. The silencing of eIF2D at efficiency of 81% has no significant effect on a11-mediated inhibition compared to which sample? Needs explanation.

14. The text describing GMP-PNP and cycloheximide from page 18 should be moved to the first mention of each inhibitor in the manuscript.

15. In Figure 7, the blots should be improved and experiments repeated in the 10T1/2 cells (that are used elsewhere in the manuscript) which mimic the embryonic development and differentiation.

16. One of the major weaknesses is that there is no functional assay to really assess the role of these findings.

https://doi.org/10.7554/eLife.66369.sa1

Author response

Given the importance of HoxA mRNAs in development the paper is of interest. The study is comprehensive and thorough. A revised version needs to address the listed below criticisms and concerns. The full text of the reviewers' comments is appended, inasmuch as they contain many additional thoughtful and constructive criticisms.

1. The mass spectral tables must be shown. Also, some validation of at least some of the data is necessary (reviewer #2).

The mass spectrometry data on complexes purified after GMP-PNP and cylcoheximide treatments are now presented as Excel files in supplementary materials (Supplementary tables 1 and 2). As presented in the manuscript, we have validated the involvement of eIF2D in TIE a3-mediated inhibition in vivo by an RNA interference approach. Importantly, eIF2D does not seem to be involved in TIE a11-mediated inhibition. Since our mass spectrometry analysis revealed that eIF2D is found only with a3 but not with a11 (Figure 6), our functional data (New Figure 7) are in agreement with our Mass Spectrometry data.

2. The ribosome binding assays are problematic and need to be rectified (reviewer #2). Reviewer #1 raised issues with peak/fraction assignments.

We acknowledge the reviewers for their constructive comments. In these experiments, we incubate 5’-capped and radiolabeled mRNA transcripts in rabbit reticulocyte lysates. The coloured sections corresponding to polysomes, 80S, 48S and RNP have been assigned according to the OD profiles at 254 nm for each sucrose gradient fractionation. To improve the clarity of the profiles, we have chosen not to superimpose all the OD profiles on top of the radioactivity curves. However, we have generated a new supplemental figure S6 showing an example of the OD profile on top of the radioactivity curves to clarify how the coloured sections have been assigned. We have also explained in more details the experiments and the coloured section assignment in figure 5C legend.

3. Figure 7A (reviewer #1). It is not clear why is it expected that reduction in eIF4E levels would interfere with TIE-mediated inhibition on translation. Also, internal controls, which are known to be (or not be) responsive to eIF4E and eIF2D suppression are lacking making it difficult to judge whether the changes in expression are specific.

The confusion comes from the fact that siRNA against eIF4E have additive effects on two mechanisms, first it affects TIE-mediated inhibition since TIE are using uORF that are translated by a cap-dependent mechanism but the siRNA against eIF4E also impacts the expression of the main ORF, the Renilla coding sequence (RL) which is translated by leaky scanning of the uORF and, more importantly the second reporter Firefly luciferase (FL) that is used for normalization. Therefore, the reviewer is right, the conception of this experiment is not appropriate. We thank the reviewer for pointing this contradiction. Indeed, we cannot use the siRNA against eIF4E in this experiment. First, we improved the presentation of the experimental procedure in figure 7A. We clearly show that the plasmid pmirGLO used harbours two reporter genes, Renilla luciferase to test the impact of TIEs and Firefly luciferase for normalization purposes. We also remodelled the presentation of this experiment and limited it to the assessment of the impact of siRNA against eIF2D only. Our current figure shows the RL/FL ratio for each co-transfection experiment. Using this ratio, we can compare the effect of silencing eIF2D to that of nontarget siRNAs in a3, a11 and pmirGLO constructs. In this latter case, the design of this experiment is appropriate since eIF2D silencing does not impact the translation of the main ORF. This is corroborated by the fact that eIF2D silencing has no impact on the second internal control reporter, Firefly luciferase. Another important result of this experiment is that silencing of eIF2D impacts specifically a3 but not a11. This also confirms our Mass Spec data that demonstrates that eIF2D is recruited specifically on a3 but not on a11. The figure 7A legend has been corrected accordingly.

4. It is not clear why specifically Hox a3 and a11 were investigated, and not the other HoxA mRNAs (reviewer #3).

We choose to work with a3 and a11 for several reasons. First, among hox, the translation mechanisms used are distinct (Xue et al., 2015). In fact some hoxA mRNAs are translated by an RPL38-mediated mechanism whereas some others do not require RPL38 to be present on the ribosome, which hints at least two different mechanisms. We wanted to investigate further an example of each of these two categories; Hox a11 mRNA translation being RPL38-dependent while Hox a3 is not. Another important criteria for the choice of a3 and a11 is their high inhibition rate of their TIE element, a3 and a11 are among the best (Xue et al., 2015). Last but not least, we chose a3 and a11 because of their small 5’UTR size, which makes them more suitable for several experiments that were conducted in our study, which required pure RNA transcripts with a high purification quality. Indeed, such experiments are more challenging with longer transcripts. These three arguments are now explained in the introduction of the revised manuscript.

5. Figure 6 (reviewer#3), both TIE a3 and a11 are showing RPL38 ribosomal protein. Why is it stated on page 38 that Hox a3 mRNA is RPL38-independent?

The reviewer is right, our mass spectrometry data showed that pre-initiation complexes assembled with both TIE elements contain RPL38. This seems to be contradictory because in the literature, only hoxa11 translation has been described to be RPL38independent (Xue et al., 2015). In fact, all the ribosomal proteins are present in these complexes, which is expected since we purified a full ribosome and we don’t expect specific depletion of RPL38 from the ribosome. This does not mean that RPL38 is needed for translation but it is present in our analysis just because it is part of the ribosome. However, the reviewer is right our statistical analysis shows that RPL38 is enriched with both a3 and a11 TIEs. Although this is interesting, so far, we have no rationale to explain this fact, we added two sentences to the manuscript to discuss this point in the result section. We also want to mention that the study from Xue et al. addresses the role of RPL38 for IRES functioning yet no study has been conducted to address the role of RPL38 for TIE functioning.

6. In vitro and cell-based experiments assessing the translational activity of reporters lack internal reference controls. What is usually used in these types of experiments is an IRES-driven reporter that can inform on non-specific inhibition events and control for transfection efficiencies

The reviewer is right, such experiments need internal controls. Concerning in vitro cellfree experiments, we did perform quality checks of our extracts using various reporter genes. Using a standard reporter construct containing the β-globin 5’UTR upstream of a Renilla coding sequence, we showed that translation is predominantly cap-dependent as expected in our self-made extracts from rabbit reticulocyte lysate. We have included in supplementary figure 1A, an additional panel that shows cap-dependency of RRL with a reporter mRNA without TIE. Concerning the in vivo experiments, we have in fact included an internal control in all our experiments. The plasmid used harbours two reporter genes, a Renilla luciferase in which we test the inhibition of TIEs and a Firefly luciferase that is translated in a canonical cap-dependent manner. All the results have been normalized against this internal control. In the revised version of the manuscript, we have clarified this point by inserting a new supplementary figure S1A for the in vitro experiments reference controls that we have used for assessing the translational activity of our cell-free extracts.

7. The paper is too long.

We have removed figure 8 and the discussion about this point to shorten the manuscript.

Reviewer #1 (Recommendations for the authors):

There are many instances (in other contexts) where uORFs or secondary structure within 5' UTRs have been found to be detrimental to translation initiation. Whereas the current study provides insight into the specific regulation of the Hox a3 and Hox a11 mRNAs, the mechanism elucidated is not particularly novel.

1. In vitro and cell-based experiments assessing the translational activity of reporters lack internal reference controls (unless I am missing something on how the data was processed). What is usually used in these types of experiments is an IRES-driven reporter that can inform on non-specific inhibition events and control for transfection efficiencies. As well, the authors have not ruled out differential mRNA stabilities contributing to reduced output from test mRNAs in any of their experiments.

Concerning RNA controls, we have answered to this point (see point 6 of general comments). For the stability of our transcripts in cell-free translation extracts, we want to emphasize that we are using capped-mRNA transcripts in addition to RNAse inhibitors. The use of these cell-free extracts has been assessed carefully in our lab since several years. In particular, we have shown previously that there is no RNA degradation is these assays (Martin et al., 2011; Mol Cell, Martin et al., 2016 Nat Comm, Gross et al., 2018 NAR, Martin et al., 2018 Nat Comm). Concerning in vivo assays, we used the plasmid pmirGlo that contains two reporters. This allows internal standardization of each assay by normalization of the same reporter in every assay. Figure 7 has been clarified to better explain the experimental procedure of our in vivo assay.

2. Figures S3B, 5C and 8 – In this ribosome binding assay, we do not see the distribution of the ribosomes throughout the gradient, only the radiolabelled counts of the mRNA are plotted as % of input. How do the authors know to assign polysomes, 80S, 48S, RNP to specific parts of the gradient? I'm assuming they are using the migration of their labelled mRNA in the presence of drugs whose mechanism of action are known to infer there the polysomes, 80S, 48S, RNP are located, but this is indirect. Normally, when these polysome binding studies are undertaken, one monitors the OD260 profile to directly observe the ribosome distribution throughout the gradient. The mRNA counts are then layered on top of this.

We acknowledge the reviewer for these constructive comments. Yes, we haven’t shown the OD profiles in purpose. We didn’t want to superimpose all the OD profiles to improve the clarity of our plots. However, we have assigned the polysomes, 80S, 48S and RNP sections according to the OD profiles. As an example, we inserted an additional supplementary figure S6 showing one OD profile on top of the sucrose gradient from figure 5. We also implemented the figures 5C and S6 legends with a better description of the assignments of each section with the OD profile. In conclusion, we believe that overlaying OD profiles on all the plots will be detrimental to the clarity of the figures and we would prefer not to show them but rather keep the coloured sections.

3. The authors undertake Mass Spect analysis of pre-initiation complexes purified by affinity chromatography and report differences in protein-RNA complexes when complexes were formed on TIE a3 versus TIE a11 globin mRNA. I couldn’t really get a sense of how well the purification worked, on the quality of the MS data, nor could I find comprehensive experimental validation performed on several of the "hits". The authors refer to eIF2D (as well as eIF1A, eIF1a-X, eIF5B, LARS, QARS, DHX21, HBS1L [p. 16]) as TIE a3 enriched factors and make the statement that this hints at two distinct TIE-mediated inhibitions. I disagree with this statement since factors, such as eIF5B, eIF1A, LARS, QARS, are required for the basic translation process and their presence will simply reflect which stage of translation is captured/enriched in the affinity chromatography experiments. I think this preliminary data is over-interpreted in its current form. Since PKR appears in the a3 and a11 complexes, is eIF2alpha phosphorylated in cells expressing these reporters?

In the revised version of the manuscript, we included the results of our Mass Spec analysis. We would like to emphasize that the complex purifications have been done in three independent experiments. Analysis of the multidimensional scaling plots, which illustrate the global variance and similarities between the GMP-PNP complexes and cycloheximide complexes detected in the replicates, after a median-to-ratio normalization, shows that our purification procedure is robust and highly reproducible. Moreover, we have used routinely this purification procedure for pre-initiation complexes isolation (Prongidi et al., 2013; Chicher et al., 2015) that allowed us to faithfully characterizer specific eIFs on CrPV IRES (Gross et al., 2017, NAR) and pre-initiation complexes assembled on histone H4 mRNA with a high purity grad that allowed further characterization and visualization by Cryo-EM (Martin et al., 2016, Nat Comm). In the volcano plots presented in the manuscript, we show only the differences between complexes. We now present as supplementary material the full datasets as supplementary tables 1 and 2. The outcome of our experiments clearly shows that we purified pre-initiation complexes that all contain ribosomal proteins and eukaryotic initiation factors indicating functional complexes.

Among specific proteins, the reviewer is right that there are other very interesting candidates. We chose to focus on eIF2D in this manuscript for further functional validation. Nevertheless, other candidates will be pursued in future studies. We added a comment in the results and in the Discussion sections in the revised manuscript on two interesting candidates, eIF5B and HBS1L as pointed out by reviewer #2. Concerning PKR, the reviewer points out an interesting question, we have not checked whether eIF2 is phosphorylated in cells expressing TIE reporters, we will also address this issue in future investigations.

4. The labelling on siRNA-eIF2D panel for TIE a3 in Figure 7 should be better positioned above the panel.

Corrected.

5. I don't understand the results with si4E in Figure 7A. Why is it expected that reduction in eIF4E levels would interfere with TIE-mediated inhibition on translation? As well, internal controls known to be (or not be) responsive to eIF4E and eIF2D suppression are lacking here in order to be able to know if changes in expression are specific.

Figure 7 has been totally remodelled in order to address the concerns from the reviewer. (see point 3 of general comments).

6. I'm not sure the cycloheximide experiment in Figure 8 adds to the understanding of the a3 TIE. It's not that complexes are "resistant" to cycloheximide (as the authors state in their subtitle), it's just that different complexes are observed compared to the reporter without the TIE 5' UTR. Without knowing the basis for these additional complexes, or their composition, this experiment is of limited value since a clear interpretation is difficult to make.

We are grateful to the reviewer for this comment. We agree that this experiment is not conclusive and although we are convinced that the unconventional profile that was observed in the presence of cycloheximide is interesting, we don’t have a rational explanation so far. Since the paper is too long (point 7), we propose to remove Figure 8 from the manuscript and the comments related to this figure (i.e. point 6 of general comments).

Reviewer #2 (Recommendations for the authors):

1. The tables for the mass spectrometry experiments were not included. These should be added.

Mass spectrometry data are presented as supplementary tables 1 and 2.

2. Based on the data presented, it seems the authors are overemphasizing the "start-stop" part of the mechanism for a11. A better wording would note the generality of the SL for a11, and a species-specific use of a "start-stop" uORF upstream of the SL.

We acknowledge this constructive comment, we have modified the manuscript accordingly.

3. All of the data points for the bar graphs should be plotted on top of the bars.

All the data presented in the histograms are the average of three independent replicas. Since the error bars are generally very small in all the presented histograms, we don’t believe that the requested modification is necessary.

Reviewer #3 (Recommendations for the authors):

1. There are 9 figures in the manuscript that should be consolidated, as it is cumbersome for the reader to follow.

As previously mentioned, we have removed figure 8.

2. What is the relation between Hox and the Drosophila genes Antp and Ubx? This is not clear in the Introduction section.

Antp and Ubx genes belong to Drosophila Hom-C cluster genes, which are the homologues of Hox genes in vertebrates. It has been shown that there exists a level of translational control due to cap-independent activity by IRES elements in these mRNAs that plays a role in development. According to Xue et al., a similar IRES-mediated mechanism controls the translation of HoxA mRNAs during embryonic development. The introduction section has been modified accordingly.

3. It is not clear why specifically Hox a3 and a11 were investigated, and not the other HoxA mRNAs.

See point 4.

4. The grammar of manuscript needs correction, and many sentences are missing appropriate punctuation which adds to confusion

Corrected.

5. The term in vivo refers to research done with or within an entire living organism. The term in vitro refers to research done outside of a living organism, this included studying cells in culture. The term in vivo should be corrected in the manuscript. OR better yet, don't use either term because they are context dependent.

The reviewer is right however we are not working on animal models and we find it is better to differentiate our in-vitro experiments performed in tubes from our cell line based experiments. So, we would prefer to keep the term in vitro for cell-free translation experiments and in vivo for those performed in cell lines.

6. The mutations performed in AUG123 from Figure S3A (right panel) are not described in the manuscript.

Corrected.

7. What does FLa3 stand for in Figure 4A?

FLa3 refers to full length 5’UTR of Hox a3 which constitutes the TIE and IRES elements. We added this detail to the figure legend.

8. Why does Figure S4B (right panel) have two lanes for Hox a3 and w/o TIE? Are they representing duplicate results? The lanes should be labeled.

These are duplicate experiments. We mentioned this in the figure legend.

9. Are the results from Figure S5 statistically significant?

Yes, the results are statistically significant. We modified the figure by adding the P values represented by the asterisks.

10. Figure 6 (middle panel) is not showing QARS, as mentioned in the manuscript on page 16, line 8.

We have modified the text in the manuscript accordingly.

11. Figure 6, both TIE a3 and a11 are showing RPL38 ribosomal protein. Why does page 38 states that Hox a3 mRNA is RPL38-independent?

This question was addressed in point #5 in the reviewing editor’s comments.

12. Page 17 lines 1-5, the percentage mentioned of 74% and 76% are respectively to Hox a3 and a11? This should be clarified.

Corrected.

13. The silencing of eIF2D at efficiency of 81% has no significant effect on a11-mediated inhibition compared to which sample? Needs explanation.

We have remodelled our figure (new figure 7) and presented a better analysis for the results. Our conclusion was based on the comparison of RL/FL values in eIF2D silencing and in the non-target pool of siRNAs. The difference between the two RL/FL values would represent the effect of eIF2D silencing on a11-mediated inhibition. Accordingly, RL/FL values upon eIF2D silencing (0.017) and upon using non-target pool of siRNAs (0.02) are almost the same then we can conclude that there is no significant effect of eIF2D silencing on a11-mediated inhibition.

14. The text describing GMP-PNP and cycloheximide from page 18 should be moved to the first mention of each inhibitor in the manuscript.

Corrected. Description of cycloheximide and GMP-PNP was moved to page 13 in the manuscript.

15. In Figure 7, the blots should be improved and experiments repeated in the 10T1/2 cells (that are used elsewhere in the manuscript) which mimic the embryonic development and differentiation.

HEK293 cell line is an embryonic cell line which expresses Hox transcript. Our protocols were optimized according to this cell line as transfection was more efficient in this cell line. Futures studies will focus on improving these experiments in 10T1/2 cell line.

16. One of the major weaknesses is that there is no functional assay to really assess the role of these findings.

We agree with this point. However, following hox expression in vivo is very challenging, it is well described that western blot for Hox protein are very difficult because reliable antibodies are not easily available. According to (Luo et al.,2019: PMID: 30866492), one of the main technological challenges to study Hox is that: “Most commercial antibodies to the HOX proteins are of very low quality (perhaps due to the strong evolutionary conservation of their protein sequences) and cannot even detect exogenously expressed high levels of the target HOX protein”.

https://doi.org/10.7554/eLife.66369.sa2

Article and author information

Author details

  1. Fatima Alghoul

    Institut de Biologie Moléculaire et Cellulaire, “Architecture et Réactivité de l’ARN” CNRS UPR9002, Université de Strasbourg, Strasbourg, France
    Contribution
    Conceptualization, Formal analysis, Investigation, Methodology, Writing - original draft
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1934-9483

  2. Schaeffer Laure

    Institut de Biologie Moléculaire et Cellulaire, “Architecture et Réactivité de l’ARN” CNRS UPR9002, Université de Strasbourg, Strasbourg, France
    Contribution
    Formal analysis, Investigation
    Competing interests
    No competing interests declared

  3. Gilbert Eriani

    Institut de Biologie Moléculaire et Cellulaire, “Architecture et Réactivité de l’ARN” CNRS UPR9002, Université de Strasbourg, Strasbourg, France
    Contribution
    Conceptualization, Formal analysis, Funding acquisition, Methodology, Writing - original draft
    Competing interests
    No competing interests declared

  4. Franck Martin

    Institut de Biologie Moléculaire et Cellulaire, “Architecture et Réactivité de l’ARN” CNRS UPR9002, Université de Strasbourg, Strasbourg, France
    Contribution
    Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration
    For correspondence
    f.martin@ibmc-cnrs.unistra.fr
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9724-4025

Funding

Agence Nationale de la Recherche (ANR-17-CE12-0025-01)

  • Franck Martin

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was funded by ‘Agence Nationale pour la Recherche’ (Ribofluidix, ANR-17-CE12-0025-01), by University of Strasbourg, and by the ‘Centre National de la Recherche Scientifique’. We would like to thank Dr Maria Barna for sharing sequences of Hoxa3 and Hox11 transcripts. We are grateful to Dr Christine Allmang, Hassan Hayek, Antonin Tidu, Aurélie Janvier, Aurélie Durand for technical assistance, Philippe Hamman, Johana Chicher, Lauriane Kuhn for mass spectrometry analysis, Dr Mireille Baltzinger and Dr Pascale Romby for support and useful discussions on the project. We would also like to thank Dr Sebastien Pfeffer for the pmirGLO plasmid.

Senior Editor

  1. James L Manley, Columbia University, United States

Reviewing Editor

  1. Nahum Sonenberg, McGill University, Canada

Version history

  1. Received: January 8, 2021
  2. Accepted: May 20, 2021
  3. Version of Record published: June 2, 2021 (version 1)

Copyright

© 2021, Alghoul et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,367
    Page views
  • 192
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fatima Alghoul
  2. Schaeffer Laure
  3. Gilbert Eriani
  4. Franck Martin
(2021)
Translation inhibitory elements from Hoxa3 and Hoxa11 mRNAs use uORFs for translation inhibition
eLife 10:e66369.
https://doi.org/10.7554/eLife.66369

Categories and tags

Research organism

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    Genetically engineered mesenchymal stem cells as a nitric oxide reservoir for acute kidney injury therapy

    Haoyan Huang, Meng Qian ... Zongjin Li
    Research Article Updated

    Nitric oxide (NO), as a gaseous therapeutic agent, shows great potential for the treatment of many kinds of diseases. Although various NO delivery systems have emerged, the immunogenicity and long-term toxicity of artificial carriers hinder the potential clinical translation of these gas therapeutics. Mesenchymal stem cells (MSCs), with the capacities of self-renewal, differentiation, and low immunogenicity, have been used as living carriers. However, MSCs as gaseous signaling molecule (GSM) carriers have not been reported. In this study, human MSCs were genetically modified to produce mutant β-galactosidase (β-GALH363A). Furthermore, a new NO prodrug, 6-methyl-galactose-benzyl-oxy NONOate (MGP), was designed. MGP can enter cells and selectively trigger NO release from genetically engineered MSCs (eMSCs) in the presence of β-GALH363A. Moreover, our results revealed that eMSCs can release NO when MGP is systemically administered in a mouse model of acute kidney injury (AKI), which can achieve NO release in a precise spatiotemporal manner and augment the therapeutic efficiency of MSCs. This eMSC and NO prodrug system provides a unique and tunable platform for GSM delivery and holds promise for regenerative therapy by enhancing the therapeutic efficiency of stem cells.

    1. Biochemistry and Chemical Biology
    2. Cell Biology

    The FAM104 proteins VCF1/2 promote the nuclear localization of p97/VCP

    Maria Körner, Susanne R Meyer ... Alexander Buchberger
    Research Article Updated

    The ATPase p97 (also known as VCP, Cdc48) has crucial functions in a variety of important cellular processes such as protein quality control, organellar homeostasis, and DNA damage repair, and its de-regulation is linked to neuromuscular diseases and cancer. p97 is tightly controlled by numerous regulatory cofactors, but the full range and function of the p97–cofactor network is unknown. Here, we identify the hitherto uncharacterized FAM104 proteins as a conserved family of p97 interactors. The two human family members VCP nuclear cofactor family member 1 and 2 (VCF1/2) bind p97 directly via a novel, alpha-helical motif and associate with p97-UFD1-NPL4 and p97-UBXN2B complexes in cells. VCF1/2 localize to the nucleus and promote the nuclear import of p97. Loss of VCF1/2 results in reduced nuclear p97 levels, slow growth, and hypersensitivity to chemical inhibition of p97 in the absence and presence of DNA damage, suggesting that FAM104 proteins are critical regulators of nuclear p97 functions.

    1. Biochemistry and Chemical Biology
    2. Epidemiology and Global Health

    Status and physiological significance of circulating adiponectin in the very old and centenarians: an observational study

    Takashi Sasaki, Yoshinori Nishimoto ... Yasumichi Arai
    Research Article

    Background: High levels of circulating adiponectin are associated with increased insulin sensitivity, low prevalence of diabetes, and low body mass index (BMI); however, high levels of circulating adiponectin are also associated with increased mortality in the 60-70 age group. In this study, we aimed to clarify factors associated with circulating high-molecular-weight (cHMW) adiponectin levels and their association with mortality in the very old (85-89 years old) and centenarians.

    Methods: The study included 812 (women: 84.4%) for centenarians and 1,498 (women: 51.7%) for the very old. The genomic DNA sequence data were obtained by whole genome sequencing or DNA microarray-imputation methods. LASSO and multivariate regression analyses were used to evaluate cHMW adiponectin characteristics and associated factors. All-cause mortality was analyzed in three quantile groups of cHMW adiponectin levels using Cox regression.

    Results: The cHMW adiponectin levels were increased significantly beyond 100 years of age, were negatively associated with diabetes prevalence, and were associated with SNVs in CDH13 (p = 2.21 × 10-22) and ADIPOQ (p = 5.72 × 10-7). Multivariate regression analysis revealed that genetic variants, BMI, and high-density lipoprotein cholesterol (HDLC) were the main factors associated with cHMW adiponectin levels in the very old, whereas the BMI showed no association in centenarians. The hazard ratios for all-cause mortality in the intermediate and high cHMW adiponectin groups in very old men were significantly higher rather than those for all-cause mortality in the low level cHMW adiponectin group, even after adjustment with BMI. In contrast, the hazard ratios for all-cause mortality were significantly higher for high cHMW adiponectin groups in very old women, but were not significant after adjustment with BMI.

    Conclusions: cHMW adiponectin levels increased with age until centenarians, and the contribution of known major factors associated with cHMW adiponectin levels, including BMI and HDLC, varies with age, suggesting that its physiological significance also varies with age in the oldest old.

    Funding: This study was supported by grants from the Ministry of Health, Welfare, and Labour for the Scientific Research Projects for Longevity; a Grant-in-Aid for Scientific Research (No 21590775, 24590898, 15KT0009, 18H03055, 20K20409, 20K07792, 23H03337) from the Japan Society for the Promotion of Science; Keio University Global Research Institute (KGRI), Kanagawa Institute of Industrial Science and Technology (KISTEC), Japan Science and Technology Agency (JST) Research Complex Program 'Tonomachi Research Complex' Wellbeing Research Campus: Creating new values through technological and social innovation (JP15667051), the Program for an Integrated Database of Clinical and Genomic Information from the Japan Agency for Medical Research and Development (No. 16kk0205009h001, 17jm0210051h0001, 19dk0207045h0001); the medical-welfare-food-agriculture collaborative consortium project from the Japan Ministry of Agriculture, Forestry, and Fisheries; and the Biobank Japan Program from the Ministry of Education, Culture, Sports, and Technology.